3 ',6 '-Bis(Ethylamino)-2 ',7 '-Dimethyl-2-{2-(E)-[(Thiophen-2-Yl)Methylideneamino]Ethyl}Spiro[Isoindo Line-1,9 '-Xanthen]-3-One Methanol Monosolvate

Qingyu Li,Rui Guo,Zhihong Xu

DOI: https://doi.org/10.1107/S1600536812018181

2012-01-01

Abstract:The title compound, C33H34N4O2S center dot CH3OH, was prepared as a spirolactam ring formation of rhodamine 6 G dye for comparison with a ring-opened form. The xanthene and spirolactam rings are approximately planar [r.m.s. deviations from planarity = 0.122 (3) and 0.072 (6) angstrom, respectively]. The dihedral angles formed by the spirolactam and thiophene rings with the xanthene ring system are 89.7 (6) and 86.5 (2)degrees, respectively. The crystal structure features N-H center dot center dot center dot O and C-H center dot center dot center dot O hydrogen bonds.

What problem does this paper attempt to address?

3&#8242;,6&#8242;-Bis(ethylamino)-2&#8242;,7&#8242;-dimethyl-2-{2-(E)-[(thiophen-2-yl)methylideneamino]ethyl}spiro[isoindoline-1,9&#8242;-xanthen]-3-one methanol monosolvate

Rui Guo,Qing-yu Li,Zhi-hong Xu

DOI: https://doi.org/10.1107/S1600536812018181

2012-01-01

Abstract:The title compound, C33H34N4O2S·CH3OH, was prepared as a spirolactam ring formation of rhodamine 6 G dye for comparison with a ring-opened form. The xanthene and spirolactam rings are approximately planar [r.m.s. deviations from planarity = 0.122 (3) and 0.072 (6) Å, respectively]. The dihedral angles formed by the spirolactam and thiophene rings with the xanthene ring system are 89.7 (6) and 86.5 (2)°, respectively. The crystal structure features N—H...O and C—H...O hydrogen bonds.
3′,6′-Bis(diethylamino)-2-[(e)-2-(4-hydroxy-3-methoxybenzylideneamino)ethyl]spiro[isoindoline-1,9′-xanthen]-3-one Ethanol Monosolvate

Zhen Wei,Jinlong Guo,Xujun Zheng,Shunwei Chen,Qun Wan

DOI: https://doi.org/10.1107/s1600536812016741

2012-01-01

Abstract:In the title compound, C(38)H(42)N(4)O(4)·C(2)H(6)O, prepared via a spiro-lactam ring-formation reaction in a rhodamine dye, the xanthene ring system is approximately planar (r.m.s. deviation = 0.0014Å) and subtends dihedral angles of 88.10 (3) and 86.92 (4)° with the spiro-lactam (r.m.s. deviations = 0.0012 Å) and benzene rings, respectively. The crystal structure consists of chains parallel to [-101], formed via O-H⋯O inter-actions.
2-[(2,4-Dihydroxybenzylidene)amino]-3&#8242;,6&#8242;-bis(ethylamino)spiro[isoindoline-1,9&#8242;-xanthen]-3-one

Zhi-Hong Xu,Yan-Ling Zhang,Yan-Ru Zhao,Feng-Ling Yang

DOI: https://doi.org/10.1107/S1600536810015126

2010-01-01

Abstract:The title compound, C35H36N4O4, was prepared as a spirolactam ring formation of rhodamine B dye for comparison with a ring-opened form. The xanthene ring system is approximately planar. The r.m.s. deviation from planarity is 0.064 (6) Å for the xanthene ring. The dihedral angles formed by the spirolactam and 2,4-dihydroxybenzene rings with the xanthene ring system are 86.6 (9) and 88.0 (9)°, respectively.
2-[(5-Chloro-2-hydroxybenzylidene)amino]-3&#8242;,6&#8242;-bis(diethylamino)spiro[isoindoline-1,9&#8242;-xanthen]-3-one

Zhi-hong Xu,Wei-yun Guo,Bo-wei Su,Xu-Ke Shen,Feng-ling Yang

DOI: https://doi.org/10.1107/S1600536810019549

2010-01-01

Abstract:The title compound, C35H35ClN4O3, resulted from a spirolactam ring closure of rhodamine B dye. The xanthene ring system is approximately planar [r.m.s. deviation = 0.050 (9) Å for the xanthene ring]. The dihedral angles formed by the spirolactam and 5-chloro-2-hydroxybenzene rings with the xanthene ring system are 87.9 (7) and 79.1 (7)°, respectively.
2-[(5-Chloro-2-hydroxybenzylidene)amino]-3′,6′-bis(diethylamino)spiro[isoindoline-1,9′-xanthen]-3-one

Zhi-hong Xu,Wei-yun Guo,Bo-wei Su,Xu-ke Shen,Feng-ling Yang

DOI: https://doi.org/10.1107/s1600536810019549

2010-01-01

Abstract:The title compound, C(35)H(35)ClN(4)O(3), resulted from a spiro-lactam ring closure of rhodamine B dye. The xanthene ring system is approximately planar [r.m.s. deviation = 0.050 (9) Å for the xanthene ring]. The dihedral angles formed by the spiro-lactam and 5-chloro-2-hy-droxy-benzene rings with the xanthene ring system are 87.9 (7) and 79.1 (7)°, respectively.
(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

Chao Wu,Yan-Jun Guo,Ai-Bao Xia

DOI: https://doi.org/10.1107/s1600536813008659

2013-01-01

Abstract:The title compound, C14H14BrNO4, contains a tricyclic ring system including three contiguous stereocenters all of which exhibit an R configuration. The cyclo-hexa-none ring adopts a chair conformation. The central oxane ring assumes a strained envelope conformation, with five of the ring atoms being nearly coplanar with the bromo-phenyl group and with the C atom adjacent to the O atom and fused with the cyclo-hexa-none ring as the flap. In the crystal, mol-ecules are linked into a three-dimensional network by C-H⋯O inter-actions.
(2S,4s)-2-[(s,e)-2-bromo-1-nitromethyl-3-phenylallyl]-4-methylcyclohexanone

Long Zhao,Chao Wu,Wen-Zeng Weng,Chu-Xia Yan,Ai-Bao Xia

DOI: https://doi.org/10.1107/s1600536812013098

2012-01-01

Acta Crystallographica Section E Structure Reports Online

Abstract:The crystal structure of the title compoud, C17H20BrNO3, contains three chiral centers, which all exhibit an S configuration. The C=C double bond has an E conformation. The cyclohexane ring is in a chair conformation. In the crystal, molecules are linked by weak N—O⋯Br interactions [O⋯Br = 3.136 (4) Å].
Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

chao wu,yanjun guo,xiaolong zhang,aibao xia

DOI: https://doi.org/10.1080/15421406.2014.928446

IF: 0.7

2015-01-01

Molecular Crystals and Liquid Crystals

Abstract:The title compound, (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one, was synthesized and characterized by H-1 and C-13 NMR and HRMS spectroscopy. Its absolute molecular configuration was investigated by X-ray crystallography. The crystal structure analysis revealed that the structure exhibits intermolecular hydrogen bonds of the type O-H horizontal ellipsis O. The methyl group and chlorophenyl group are located in the cis configuration. The conformation is stabilized by weak intermolecular C-H... O interactions.
(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

Benguo Lin,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536813002560

2013-01-01

Abstract:In the title compound, C(28)H(33)NO(4)·CH(2)Cl(2), the pyrrolidone ring adopts a twisted envelope conformation and the cyclo-hexene has a half-chair conformation. In the crystal, weak C-H⋯O hydrogen bonds link the components into chains along [100].
(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

Jian Zhao,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536810017010

2010-01-01

Abstract:The title compound, C(28)H(26)N(2)O(4), crystallizes as a racemate with four stereogenic centers. In the molecule, the pyrrolidone ring adopts an envelope conformation and the cyclohexene ring has a twisted envelope conformation. In the crystal structure, molecules are linked by weak intermolecular C-H center dot center dot center dot O hydrogen bonds.
(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

Yongzhou Hu,Huazhou Ying

DOI: https://doi.org/10.1107/S1600536805001807

2005-01-01

Abstract:The title compound, C27H24Cl3N3O7S, contains a thiadiazoline ring which is almost planar. The two ethoxy groups bonded at the 3a- and 4-positions are in a trans configuration.
(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1H-2,3-benzoxazin-4-one

Yan Wang,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536809044195

2009-01-01

Abstract:In the title compound, C28H27NO2, the oxazinone ring adopts a twist-boat conformation and the cyclohexene ring has a twisted envelope conformation. The crystal structure is stabilized by weak non-classical intermolecular C—H...O hydrogen bonds.
3-[(2R*,3s*)-3-(4-chlorophenyl)-3-(2-methoxyanilino)-2-methylpropionyl]spiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

SZ Jian,JM Gu,YG Wang

DOI: https://doi.org/10.1107/s1600536805007361

2005-01-01

Acta Crystallographica Section E Structure Reports Online

Abstract:The racemic title compound, C30H32N2O4, was synthesized from spiro[2H- 1,3-benzoxazine-2,1'-cyclohexan]-4(3H)-one and N-benzylidene-2-methoxybenzenamine under classical Reformatsky reaction conditions. Intermolecular N - H center dot center dot center dot O and C - H center dot center dot center dot O hydrogen bonds link the molecules in the crystal structure into infinite chains along the a axis. These chains form layers parallel to the ( 001) plane, which are stabilized by weak interlayer C - H center dot center dot center dot O hydrogen bonds.
(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

Yong-Zhou Hu,Hua-Zhou Ying

DOI: https://doi.org/10.1107/s1600536805001807

2005-01-01

Abstract:The title compound, C27H24Cl3N3O7S, contains a thiadiazoline ring which is almost planar. The two ethoxy groups bonded at the 3a- and 4-positions are in a trans configuration.
rac-7-[(2E)-But-2-enoyl]-13-chloro-N-cyclohexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide

Ning Ye,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536812005946

2012-01-01

Acta Crystallographica Section E Structure Reports Online

Abstract:In the title compound, C31H29ClN2O3, the two heterocyclic rings, belonging to a system of five condensed rings, adopt conformations intermediate between twist-boat and sofa. The secondary amide group is involved in a weak intramolecular N—H...N hydrogen bond. In the crystal, molecules are linked by pairs of C—H...Cl hydrogen bonds to form inversion dimers. These dimers are linked via a C—H...O interaction to form chains propagating along the b-axis direction.
(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

Qing Yuan,Ming Lei

DOI: https://doi.org/10.1107/s1600536806017296

2006-01-01

Abstract:The absolute configuration of the title compound, C20H26BrNO3, was determined from both the synthetic precursor and anomalous scattering effects. In the crystal structure, non-classical C—H...O hydrogen bonds link the molecules into a sheet parallel to the b axis.
Ethyl (4aR*,7S*,8S*,8aS*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1H-isochromene-8-carboxylate

Xiu Qing Jiang,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536810017009

2010-01-01

Abstract:In the title compound, C18H20O4, both the tetrahydropyranone ring and the cyclohexene ring adopt envelope conformations. The crystal packing is stabilized by weak intermolecular C—H⋯O hydrogen bonding.
(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitrophenyl)‐4‐(4‐chlorophenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thiadiazoline

Yongzhou Hu,Huazhou Ying

DOI: https://doi.org/10.1107/s1600536805001807

2005-01-01

Abstract:The title compound, C27H24Cl3N3O7S, contains a thiadiazoline ring which is almost planar. The two ethoxy groups bonded at the 3a- and 4-positions are in a trans configuration.
rac-7-[(2E)-But-2-eno-yl]-13-chloro-N-cyclo-hexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide.

Ning Ye,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536812005946

2012-01-01

Abstract:In the title compound, C(31)H(29)ClN(2)O(3), the two heterocyclic rings, belonging to a system of five condensed rings, adopt conformations intermediate between twist-boat and sofa. The secondary amide group is involved in a weak intramolecular N-H⋯N hydrogen bond. In the crystal, molecules are linked by pairs of C-H⋯Cl hydrogen bonds to form inversion dimers. These dimers are linked via a C-H⋯O interaction to form chains propagating along the b-axis direction.
(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

Hao Shi,Hong Xiang Sun

DOI: https://doi.org/10.1107/s1600536808043341

2008-01-01

Abstract:The title compound, C24H32O8S center dot C3H6O, features three six-membered and two five-membered rings. The six-membered rings adopt chair, boat and slightly distorted boat conformations whereas one five-membered ring adopts an approximate envelope conformation and the other a twist conformation. Disorder was modelled for the ethylthio group with the ethyl-C atoms resolved over three positions with occupancies of 0.58 (4), 0.23 (4) and 0.19 (3). In the crystal, an O-H center dot center dot center dot O hydrogen bond links the molecules into chains.

3 ',6 '-Bis(Ethylamino)-2 ',7 '-Dimethyl-2-{2-(E)-[(Thiophen-2-Yl)Methylideneamino]Ethyl}Spiro[Isoindo Line-1,9 '-Xanthen]-3-One Methanol Monosolvate

3&#8242;,6&#8242;-Bis(ethylamino)-2&#8242;,7&#8242;-dimethyl-2-{2-(E)-[(thiophen-2-yl)methylideneamino]ethyl}spiro[isoindoline-1,9&#8242;-xanthen]-3-one methanol monosolvate

3′,6′-Bis(diethylamino)-2-[(e)-2-(4-hydroxy-3-methoxybenzylideneamino)ethyl]spiro[isoindoline-1,9′-xanthen]-3-one Ethanol Monosolvate

2-[(2,4-Dihydroxybenzylidene)amino]-3&#8242;,6&#8242;-bis(ethylamino)spiro[isoindoline-1,9&#8242;-xanthen]-3-one

2-[(5-Chloro-2-hydroxybenzylidene)amino]-3&#8242;,6&#8242;-bis(diethylamino)spiro[isoindoline-1,9&#8242;-xanthen]-3-one

2-[(5-Chloro-2-hydroxybenzylidene)amino]-3′,6′-bis(diethylamino)spiro[isoindoline-1,9′-xanthen]-3-one

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

(2S,4s)-2-[(s,e)-2-bromo-1-nitromethyl-3-phenylallyl]-4-methylcyclohexanone

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

3-[(2R,3s)-3-(4-chlorophenyl)-3-(2-methoxyanilino)-2-methylpropionyl]spiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

<i>rac</i>-7-[(2<i>E</i>)-But-2-enoyl]-13-chloro-<i>N</i>-cyclohexyl-7,8-dihydro-5<i>H</i>-isochromeno[4,3-<i>c</i>]phenanthridine-8-carboxamide

(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitrophenyl)‐4‐(4‐chlorophenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thiadiazoline

rac-7-[(2E)-But-2-eno-yl]-13-chloro-N-cyclo-hexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide.

(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

3 ',6 '-Bis(Ethylamino)-2 ',7 '-Dimethyl-2-{2-(E)-[(Thiophen-2-Yl)Methylideneamino]Ethyl}Spiro[Isoindo Line-1,9 '-Xanthen]-3-One Methanol Monosolvate

3&amp;#8242;,6&amp;#8242;-Bis(ethylamino)-2&amp;#8242;,7&amp;#8242;-dimethyl-2-{2-(E)-[(thiophen-2-yl)methylideneamino]ethyl}spiro[isoindoline-1,9&amp;#8242;-xanthen]-3-one methanol monosolvate

3′,6′-Bis(diethylamino)-2-[(e)-2-(4-hydroxy-3-methoxybenzylideneamino)ethyl]spiro[isoindoline-1,9′-xanthen]-3-one Ethanol Monosolvate

2-[(2,4-Dihydroxybenzylidene)amino]-3&amp;#8242;,6&amp;#8242;-bis(ethylamino)spiro[isoindoline-1,9&amp;#8242;-xanthen]-3-one

2-[(5-Chloro-2-hydroxybenzylidene)amino]-3&amp;#8242;,6&amp;#8242;-bis(diethylamino)spiro[isoindoline-1,9&amp;#8242;-xanthen]-3-one

2-[(5-Chloro-2-hydroxybenzylidene)amino]-3′,6′-bis(diethylamino)spiro[isoindoline-1,9′-xanthen]-3-one

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

(2S,4s)-2-[(s,e)-2-bromo-1-nitromethyl-3-phenylallyl]-4-methylcyclohexanone

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

(1<i>S</i>*,4a<i>R</i>*,5<i>S</i>*,6<i>S</i>*,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

3-[(2R*,3s*)-3-(4-chlorophenyl)-3-(2-methoxyanilino)-2-methylpropionyl]spiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

<i>rac</i>-7-[(2<i>E</i>)-But-2-enoyl]-13-chloro-<i>N</i>-cyclohexyl-7,8-dihydro-5<i>H</i>-isochromeno[4,3-<i>c</i>]phenanthridine-8-carboxamide

(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

Ethyl (4a<i>R</i>*,7<i>S</i>*,8<i>S</i>*,8a<i>S</i>*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitro­phenyl)‐4‐(4‐chloro­phenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thia­diazo­line

rac-7-[(2E)-But-2-eno-yl]-13-chloro-N-cyclo-hexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide.

(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

3′,6′-Bis(ethylamino)-2′,7′-dimethyl-2-{2-(E)-[(thiophen-2-yl)methylideneamino]ethyl}spiro[isoindoline-1,9′-xanthen]-3-one methanol monosolvate

2-[(2,4-Dihydroxybenzylidene)amino]-3′,6′-bis(ethylamino)spiro[isoindoline-1,9′-xanthen]-3-one

2-[(5-Chloro-2-hydroxybenzylidene)amino]-3′,6′-bis(diethylamino)spiro[isoindoline-1,9′-xanthen]-3-one

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

3-[(2R,3s)-3-(4-chlorophenyl)-3-(2-methoxyanilino)-2-methylpropionyl]spiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitrophenyl)‐4‐(4‐chlorophenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thiadiazoline